Introduction

Introducing Conjugate Pneumococcal Vaccine at EPI Schedule in
Bangladesh -Impact on Sustainable Development Goal 
Pneumococcal Conjugate Vaccine: A newer vaccine available in Bangladesh
Streptococcus pneumoniae, or pneumococcus, causes pneumonia and infections of the brain and blood that is responsible for mortality in children under five years. Pneumococcal diseases are a major public health problem worldwide. S. pneumoniae is a Grampositive encapsulated cocci. Based on differences in the composition of the polysaccharide capsule, about 90 serotypes have been identified. 7 The capsule is an essential virulence factor. The majority of cases of pneumococcal diseases in infants is associated with a small number of these serotypes, which are vary by region. Pneumococci are transmitted by direct contact with respiratory secretions from patients and healthy carriers. Pneumococcal resistance to essential antimicrobials such as penicillins, cephalosporins and macrolides is a serious and rapidly increasing problem worldwide. Facilities for laboratory diagnosis of S. pneumoniae, based on growth in traditional culture media, are available in laboratories for routine clinical microbiology, whereas serotyping is performed only in reference laboratories.
S. pneumoniae is responsible for 15-50% of all episodes of community-acquired pneumonia, 30-50% of all cases of acute otitis media and a significant proportion of bacterial meningitis and bacteremia. 6, 8 However, based on available data, acute respiratory infections kill an estimated 2.6 million children less than five years of age annually. S. pneumoniae kills at least one million children under the age of five every year, a sum that is more than malaria, AIDS and measles combined. More than 70% of the deaths are in developing countries. Pneumoniae is by far the most common cause of pneumococcal death worldwide. 11 Based on the available data and policy options before it, Bangladesh can take several important steps to prevent pneumonia and improve child survival through the expanded use of life-saving pneumonia vaccines.
Recommendations for Pneumococcal Conjugate Vaccines PCVs in Bangladesh
The burden of pneumococcal disease is the greatest among the underprivileged children in Bangladesh. The PCVs are thus of public health importance and ideally should be available to all children. However the high cost of PCVs and the limited coverage of the currently available vaccine are impediments. Global Alliance for Vaccine & Immunization (GAVI) has offered to supply PCV at a cost of 0.15-0.3 USD/dose to Bangladesh for inclusion in the national immunization schedule and commits to extending this support until the year 2025.
Schedule for Pneumococcal Conjugate Vaccine
Bangladesh Health Ministry & Bangladesh Pediatrics Association(BPA) recommends 3 doses at 6, 10 and 14 weeks with a booster at 15 month. Infants receiving their first dose at age <11 month should receive 3 doses of PCV10 at intervals of approximately 4 weeks with a booster at 15 month. Children aged 12-23 months should receive 2 doses with an interval of at least 8 weeks between doses. 12 The risk of invasive pneumococcal disease is significantly lower in healthy children above the age of 2 years and vaccination with single dose of PCV vaccine may be considered in children aged 2-5 years. 13 Pneumococcal vaccination in not recommended in children aged 5 and above. The recommended dosage for is 0.5mL, and the vaccination route is intramuscular.
Vaccine Safety
The safety of PCV10 was assessed in 10 studies and it contains 10 different serotypes of pneumococcus.
Where over 30,000 healthy infants were aged under 7 month administered at least 1 dose of PCV10 and over 24,000 children aged 6-16 month received at least 1 dose of PCV10 with other routine pediatric vaccines. The most commonly reported (more than 20% of subjects) adverse reactions were injection-site reactions, fever, decreased appetite, irritability, and increased or decreased sleep. The frequency and severity of local reactions at the injection site (pain/ tenderness, redness of the skin, and induration/ swelling) and systemic reactions (irritability, drowsiness/increased sleep, decreased appetite, fever and restless sleep/decreased sleep) were similar in the PCV10. 14, 15 Achievements of EPI in Bangladesh 16, 17 • In Bangladesh 78% (0-11 months) children fully immunized (BDHS-2014) and 41.8 million children immunized against measles & Rubella through special campaign in 2013.
• TT Immunization to target women (15-49 yrs.) in 6 high risk Districts in rural area.
• The coverage for the penta-valent and polio vaccines is 97 percent each for the first dose and 91 percent each for the third dose.
• Only 2 percent of children age 12-23 months has not received any vaccinations.
• Vitamin-A supplementation-twice a year with coverage >95%.
• Storage capacity enhanced for the buffer stocks of all vaccines for the period of 3 months.
• Improved monitoring & supervision through provision of 59 single cabin vehicles for DO(H) under Global Alliance for Vaccine & Immunization (GAVI).
• Provisions of 3652 motorcycles to EPI staff were given by GAVI.
• Provision of cold chain equipment to 8 flood hit districts.
• Capacity building of health managers and EPI staff (17,804).
• Orientation training workshops for medical officers, LHVs, LHWs etc.
• Training of health personnel for cold chain repair and maintenance.
• Training workshops for vaccine stock management carried out in all districts during 2010 & 2011.
• Introduction of Rota virus vaccine within 2016.
Conclusion
Currently, vaccines against nine diseases are being administered to children under 1 year. The full coverage is more than 85 percent, an achievement that helped Bangladesh to become one of the six countries in the world that achieved MDG on child mortality before the 2015 deadline. Global Alliance for Vaccine & Immunization (GAVI) also awarded Bangladesh twice for the best coverage in the world. As pneumonia causes 20,000 deaths of children under five every year, introducing the pneumococcal vaccination will save many lives. Starting PCV is a great achievement of Bangladesh Government. This indicates that we are not too much far from 2022 vision. If our government keep this sustainable progression in health sector we can easily achieve our goal.
